Database for Interstitial Lung Disease

Last updated: October 7, 2024
Sponsor: Medical University of Graz
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

chest CT

Clinical Study ID

NCT04707781
33-023 ex 20/21
  • Ages > 18
  • All Genders

Study Summary

The purpose of this study is to establish a clinical database for patients bearing at risk for ILD (Interstitial Lung Disease) and to set up a prospective ILD Screening program for these patients.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age: ≥ 18 years

  • patients with a known systemic disease bearing a risk for ILD

  • signed informed consent (for prospective part)

Exclusion

Exclusion Criteria:

  • Age < 18 years

  • comorbidities severely limiting life-expectancy (e.g. severe cardiovascularconditions, malignant disease)

Study Design

Total Participants: 412
Treatment Group(s): 1
Primary Treatment: chest CT
Phase:
Study Start date:
May 01, 2021
Estimated Completion Date:
January 31, 2026

Connect with a study center

  • Medical University of Graz, Department of Internal Medicine, Division of Pulmonology

    Graz, 8036
    Austria

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.